Cognex Corporation (CGNX) Stock: Price, Forecast & Analyst Target
Cognex Corporation (CGNX) — MoonshotScore 81/100 (Exceptional band), calculated Nov 18, 2026. Price $49.13 (+1.30%), as of the Nov 18, 2026 trading session; market cap $8.27B. Expected results Feb 10, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Market value / cash and short-term investments: 11.89× (cash as of Oct 4, 2026) · expected results Feb 10, 2027
Cognex Corporation · CGNX · NASDAQ · Technology · Hardware, Equipment & Parts
Research dated 2026-09-13: Cognex sells machine-vision software, sensors, integrated vision systems and barcode readers that help factories and logistics operations identify, inspect, measure and track goods. Customer spending on automation is the demand engine; the case hinges on whether the latest sales recovery can keep producing faster profit growth without weakening the company's unusually strong balance sheet.
Price as of Nov 18, 2026
Key Statistics
MoonshotScore v2 · Cognex (CGNX)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality, a fortress balance sheet and durable growth, but an expensive valuation. Business Quality: Elite; Financial Safety: Fortress; Valuation: Rich; Growth Durability: Growing; Momentum: Rising.
- quarterly revenue $277M (Q3 FY2025, quarter ended Sep 2025)
- EPS beat 8 of the last 8 reports
- Altman Z 10.52 · Piotroski F 7
Helping: business quality, balance-sheet strength, durable growth
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 78 | Strong | |
| 78 | Strong | |
| 78 | Strong | |
| 78 | Strong | |
| 81 | Exceptional | |
| 81 | Exceptional |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $49.13 | |
| Change on the day | +1.30% | |
| 52-week range | $34.60–$72.88 | |
| Market capitalisation | $8.27B | — |
| Price / earnings (trailing) | 33.68 | |
| Shares traded on the day | 1.61M | |
| Beta (volatility vs the S&P 500) | 1.48 | |
| Dividends per share (last 12 months) | $0.26 | |
| Dividend yield (last 12 months) | 0.53% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings call · management outlook
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
For Q4, we expect revenue of $270 million-$290 million, representing approximately 11% growth at the midpoint and in line with seasonality and a strong electronics growth year.
Dennis Fehr · Statement from
For 2026, we now expect revenue of $1.14 billion-$1.16 billion.
Dennis Fehr · Statement from
How to read these dates
Events are in date order; the spacing is not a duration scale. A statement's date is the earnings call where it was made, not a deadline. Management expectations and estimated dates can change.
Other perspectives
Council score for Cognex (CGNX): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
4 lenses, 4 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 18, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Cognex (CGNX), and what does it report?
Short answer
Cognex Corporation specializes in machine vision technology, offering solutions that interpret and process visual data to streamline and automate production and logistics operations globally.
Research dated 2026-09-13.
Cognex is not simply a hardware maker. VisionPro, QuickBuild and deep-learning software interpret images, while In-Sight systems, vision sensors and DataMan readers apply that intelligence to inspection, robotic guidance, identification and traceability across consumer electronics, automotive, pharmaceutical, medical-device and other production lines.
Reported revenue overwhelmingly comes from standard products and services, with customer-specific solutions forming the smaller activity. The accounts therefore measure broad adoption of a repeatable vision platform more than the expansion of a bespoke engineering consultancy.
What do the latest results show for Cognex (CGNX)?
Short answer · as of
The most recent reported quarter, Q3 FY2025, carried revenue of $277M.
Research dated 2026-09-13.
The latest reported period extended the recovery: revenue, gross profit, operating profit, net income and diluted earnings all rose from the preceding period. Operating profit advanced much faster than sales as research and selling and administrative expense declined, indicating meaningful operating leverage rather than growth purchased through a matching rise in overhead.
Reported earnings again exceeded the prevailing estimate, although revenue finished slightly below its estimate after several periods of stronger-than-expected sales. Management subsequently called for continued near-term growth and a stronger full-period result; that is an outlook, while the completed income statement and cash-flow record are the evidence that momentum had already improved.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $313.39M Oct 4, 2026
- Latest quarter · R&D
- $33.90M Oct 4, 2026
- Latest quarter · SG&A
- $87.02M Oct 4, 2026
- Latest quarter · FMP standardized operating result
- $100.82M Oct 4, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Oct 4, 2026 | $313.39M | $33.90M | $87.02M | $100.82M |
| Jul 5, 2026 | $291.26M | $32.39M | $87.86M | $85.52M |
| Apr 5, 2026 | $268.44M | $37.02M | $94.04M | $59.87M |
| Dec 31, 2025 | $252.34M | $36.06M | $94.57M | $35.28M |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $313.39M Nov 4, 2026
- Latest report · revenue estimate
- $313.62M Nov 4, 2026
- Latest report · revenue vs estimate
- Below estimate Nov 4, 2026
- Latest report · EPS vs estimate
- Above estimate Nov 4, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Nov 4, 2026 | $313.39M | $313.62M | $0.5300 | $0.5180 |
| Aug 5, 2026 | $291.26M | $292.10M | $0.4500 | $0.4238 |
| May 6, 2026 | $268.44M | $245.98M | $0.3400 | $0.2483 |
| Feb 11, 2026 | $252.34M | $238.99M | $0.2700 | $0.2200 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2025 | $277M | $18M | $0.10 (diluted) |
| Q4 FY2025 | $252M | $33M | $0.19 (diluted) |
| Mar 2026 | $268M | $52M | $0.31 (diluted) |
| Jun 2026 | $291M | $73M | $0.43 (diluted) |
What are the financial strengths and risks for Cognex (CGNX)?
Short answer
Cash and short-term investments were $695.69M at the Oct 4, 2026 balance-sheet date. Operating cash flow was $106.42M for the quarter ended Oct 4, 2026, meaning operations generated cash. These figures do not establish a cash runway.
Research dated 2026-09-13.
Cognex pairs positive operating cash generation with modest capital expenditure, a valuable structure for a business whose core assets include software and vision expertise. Cash and investments stand far above debt, the liquid balance has risen markedly across recent periods, and the distress and quality screens point in the same direction.
The vulnerability is customer willingness to deploy or upgrade automation systems across cyclical manufacturing markets. Earlier annual results show that revenue can retreat and profit can fall more sharply, while the current valuation places a rich price on sales, earnings and free cash flow; weaker demand or lost operating leverage would therefore matter more than refinancing pressure.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $106.42M Oct 4, 2026
- Previous quarter · operating cash flow
- $69.15M Jul 5, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Oct 4, 2026 | $106.42M | −$2.64M |
| Jul 5, 2026 | $69.15M | −$1.53M |
| Apr 5, 2026 | $45.09M | −$2.76M |
| Dec 31, 2025 | $74.90M | −$2.60M |
How to read these figures
Amounts are in US dollars. Negative operating cash flow means the business used cash. Capital spending is shown as reported; we do not combine it into a free-cash-flow or runway estimate. The bars share one scale.
What should you watch next at Cognex (CGNX)?
Short answer · as of
The next earnings report is expected on Feb 10, 2027. The number it tests is the $1.71 EPS analysts carry for it.
Research dated 2026-09-13.
The next earnings release should be tested against management's growth outlook and the recent sequence of rising quarterly revenue. The more revealing checks are whether operating profit continues to outpace sales, whether research and selling costs remain controlled without impairing product development, and whether operating cash flow keeps converting the accounting gains.
Consensus assumes revenue expansion continues into later periods, but the range of expectations broadens and analyst coverage thins further out. Sustained growth across In-Sight, DataMan and the software portfolio, accompanied by durable margins and cash conversion, would support that trajectory; a return to expense growth ahead of sales would challenge it.
What management is planning
Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.
Even after those impacts, we expect to deliver strong double-digit revenue growth, more than 1,000 basis points of adjusted EBITDA margin expansion, and greater than 70% adjusted EPS growth this year.
Dennis Fehr ·
Relative to Q3, we expect gross margin to moderate modestly, reflecting a less favorable revenue mix due to electronic seasonality.
Dennis Fehr ·
What the records here don't tell us
- The newest quarter held here (Q3 FY2025) was filed Oct 30, 2025 — 12 months ago.
Checked against the records this page reads, on the dates shown above.
How does Cognex compare with its peers?
Short answer
Cognex's score ranks 2nd of 6 in the bounded comparison shown, against 5 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13.
Compared with conventional industrial equipment suppliers, Cognex spans the interpretation layer and the device layer: development software, deep-learning tools, integrated vision systems, sensors and image-based barcode readers. That combination lets the same platform address inspection, measurement, robotic guidance and traceability rather than depend on a narrow equipment category.
Its reporting mix also differs from a project-heavy automation integrator. Standard products and services dominate customer-specific solutions, while low capital expenditure and strong gross profitability show an economically light operating footprint despite the physical hardware.
| Company | Price | Market value | Score |
|---|---|---|---|
| $91.06 Nov 18, 2026 | $7.79B | 93 5-pillar Nov 18, 2026 | |
| Cognex (CGNX) — this page | $49.13 | $8.27B | 81 |
| $228.54 Nov 18, 2026 | $5.92B | 70 5-pillar Nov 18, 2026 | |
| $157.57 Nov 18, 2026 | $8.45B | 69 5-pillar Nov 18, 2026 | |
| $386.71 Nov 18, 2026 | $9.82B | 64 5-pillar Nov 18, 2026 | |
| $69.41 Nov 18, 2026 | $7.31B | 57 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $64.00 – $91.00
- Consensus target
- $74.30
- Median target
- $74.50
- Revenue estimate
- $1.15B
- EPS estimate
- $1.71
Consensus record · Captured .
Measured against a quoted price of $49.13 (as of Nov 18, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Aug 11, 2026
- Transactions
- 26
- Identified insiders
- 2
- Purchases
- 0
- Sales
- 6
- Other transactions
- 20
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
- Reporting holders
- 672 Period end Sep 30, 2026
- Previous quarter · holders
- 682 Prior to period end Sep 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Blackrock, INC. | 16,987,331 |
| Vanguard Portfolio Management LLC | 9,871,887 |
| Invesco Ltd. | 8,517,786 |
| Vanguard Capital Management LLC | 7,529,894 |
| Pictet Asset Management Holding SA | 5,985,986 |
Tracked investors
Which of the 16 named investors we follow held CGNX in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported CGNX in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Holder snapshot as of Sep 30, 2026. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Cognex (CGNX)?
Common Questions About CGNX (Technology)
Research dated 2026-09-13; the full attribution is under Sources. The last 3 questions are answered from this page's own dated data, not from the research.
What do Cognex In-Sight systems do on a production line?
In-Sight combines vision processing with integrated systems and sensors to locate parts, confirm identities, measure dimensions, validate assembly and guide robots. Demand follows the number and complexity of inspection tasks manufacturers choose to automate.
How does DataMan differ from Cognex inspection products?
DataMan reads and verifies image-based barcodes, extending Cognex from visual inspection into identification and traceability. It helps track components and finished goods as they move from production toward delivery.
Is Cognex mainly a custom machine-vision integrator?
Standard products and services account for most reported revenue, while customer-specific solutions are the smaller activity. Cognex therefore depends more on adoption of repeatable products such as VisionPro, In-Sight and DataMan than on bespoke project work.
Why do consumer electronics and automotive spending matter to Cognex?
Those manufacturers use Cognex tools to inspect, measure, identify and track parts during automated production. Delayed line installations or upgrades can restrain demand, while broader automation programs create more opportunities for software, sensors, vision systems and readers.
What is the CGNX stock price today?
The last price recorded for Cognex Corporation (CGNX), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the CGNX price target?
The analyst consensus price target for Cognex Corporation (CGNX), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Does CGNX pay a dividend?
Yes. The dividend yield of Cognex Corporation (CGNX) over the last 12 months, with its date, is listed under Price & valuation on this page. Payout ratio and cash-flow coverage decide whether it can last, and past dividends do not guarantee future payments.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 86 figures on this page — 2 from SEC filings and earnings calls, 73 from Financial Modeling Prep (FMP), 5 with no recorded source, 5 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources (as of 2026-09-13), by section of the research
ETFs that hold CGNX
Funds in our ETF coverage that list CGNX among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| ALPS Electrification Infrastructure ETF (ELFY) | 1.30% |